ReviewCancers2021

Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond.

Boris Bozic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.